2024
Can Contrast Injections Cause or Propagate Coronary Injuries? Insights From Vessel and Guiding Catheter Hemodynamics
Chamié D, Bahl R, Maia J, Echavarria-Pinto M, Gafore S, Saleh A, Cristea E, Seligman H, Joaquim R, Feres F, Sen S, Al-Lamee R, Centemero M, Baker C, Johnson T, Shun-Shin M, Lansky A, Petraco R. Can Contrast Injections Cause or Propagate Coronary Injuries? Insights From Vessel and Guiding Catheter Hemodynamics. Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 102396. DOI: 10.1016/j.jscai.2024.102396.Peer-Reviewed Original Research
2013
The collateral circulation of the heart
Meier P, Schirmer SH, Lansky AJ, Timmis A, Pitt B, Seiler C. The collateral circulation of the heart. BMC Medicine 2013, 11: 143. PMID: 23735225, PMCID: PMC3689049, DOI: 10.1186/1741-7015-11-143.Peer-Reviewed Original ResearchConceptsCoronary artery diseaseCollateral arteriesArtery diseaseCollateral circulationCoronary arteryOcclusive coronary artery diseaseRelevant protective roleEpicardial coronary arteriesFirst clinical trialIntracoronary pressure measurementsRecent pilot studyExternal counterpulsationEnd arteriesClinical trialsBlood supplyArteryProtective roleGranulocyte colonyAnastomotic vesselsPilot studyGrowth factorGold standardDiseasePressure measurementsVessels
2010
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial.
Applegate RJ, Hermiller JJ, Sanz M, Doostzadeh J, Pierson W, Su X, Lansky AJ, Sudhir K, Stone GW. Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial. EuroIntervention 2010, 6: 437-46. PMID: 20884430, DOI: 10.4244/eij30v6i4a75.Peer-Reviewed Original ResearchConceptsPaclitaxel-eluting stentsClinical outcomesStent typeMajor adverse cardiac eventsTwo-year event ratesSPIRIT IIIPaclitaxel-eluting coronary stentsSPIRIT III trialYear clinical outcomesAdverse cardiac eventsCardiac eventsIII trialsPE groupTwo-vesselPatientsEvent ratesCoronary stentsTrialsVessel treatmentStentsOutcomesVesselsSignificant interactionStentingLesions
1998
Rheolytic thrombectomy in the treatment of acute limb‐threatening ischemia: Immediate results and six‐month follow‐up of the multicenter AngioJet® registry
Silva J, Ramee S, Collins T, Jenkins J, Lansky A, Ansel G, Dolmatch B, Glickman M, Stainken B, Ramee E, White C. Rheolytic thrombectomy in the treatment of acute limb‐threatening ischemia: Immediate results and six‐month follow‐up of the multicenter AngioJet® registry. Catheterization And Cardiovascular Interventions 1998, 45: 386-393. PMID: 9863742, DOI: 10.1002/(sici)1097-0304(199812)45:4<386::aid-ccd7>3.0.co;2-q.Peer-Reviewed Original ResearchConceptsLimb-threatening ischemiaAcute limb-threatening ischemiaRheolytic thrombectomyLimb salvageHigh-risk surgical patientsNonvascular causesInitial angiogramSevere comorbiditiesSurgical patientsProcedural successThrombolytic therapyImmediate blood flowBlood flowSix monthsPatientsThrombectomyIschemiaContraindicationsImmediate resultsHospitalLimbSalvageSurvivorsVesselsComorbidities